Epigenetic Inactivation of the SFRP1 Gene in Esophageal Squamous Cell Carcinoma
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The secreted frizzled-related protein 1 (SFRP1) gene, as a Wnt signaling modulator, is frequently inactivated by promoter methylation in many tumors including gastric cancer, breast cancer, oral squamous cell carcinoma, and esophageal adenocarcinoma. However, the role of SFRP1 in esophageal squamous cell carcinoma (ESCC) is not clear. In this study, we investigated the epigenetic inactivation of the SFRP1 gene in ESCC.
Nine ESCC cell lines, two immortalized human esophageal epithelial cell lines, twenty ESCC tissues, and paired adjacent nontumor tissues were analyzed in the study. Methylation-specific polymerase chain reaction (PCR), bisulfite sequencing, reverse-transcription PCR, immunohistochemistry, and chromatin immunoprecipitation assay were used to detect SFRP1 promoter methylation, expression of the SFRP1 gene, and histone modification in the SFRP1 promoter region.
The SFRP1 promoter was found to be highly methylated in 95% (19/20) of the ESCC tissues and in nine ESCC cell lines, compared with 65% (13/20) of the paired nontumor tissues. Moreover, we confirmed that complete methylation of the SFRP1 gene promoter was correlated with its greatly reduced expression level. After individual treatment with 5-aza-2′-deoxycytidine (DAC) and trichostatin A (TSA), the messenger RNA (mRNA) level of the SFRP1 gene was not obviously rescued in the EC9706 cell line. Combined incubation with DAC and TSA can, however, substantially increase the SFRP1 mRNA expression level in the EC9706 cell line. Chromatin immunoprecipitation assay showed that acetylated histone H3 and H4 were found in the SFRP1 promoter region.
Promoter hypermethylation of SFRP1 is a frequent event in ESCC. Promoter methylation and histone acetylation may cooperatively regulate expression of the SFRP1 gene.
- Guo M, Ren J, House MG, et al. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2006;12:4515–4522. CrossRef
- Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613–619. CrossRef
- Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–1413.
- Yokokawa Y, Ohta S, Hou J, et al. Ecological study on the risks of esophageal cancer in ci-xian, china: the importance of nutritional status and the use of well water. Int J Cancer. 1999;83:620–624. CrossRef
- Aragones N, Ramis R, Pollan M, et al. Oesophageal cancer mortality in Spain: a spatial analysis. BMC Cancer. 2007;7:3. CrossRef
- Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042–2054. CrossRef
- Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol. 2007;40:142–150. CrossRef
- Ishii T, Murakami J, Notohara K, et al. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut. 2007;56:13–19. CrossRef
- Ying J, Li H, Seng TJ, et al. Functional epigenetics identifies a protocadherin pcdh10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene. 2006;25:1070–1080. CrossRef
- Wang Y, Li J, Cui Y, et al. Cmtm3, located at the critical tumor suppressor locus 16q22.1, is silenced by cpg methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res. 2009;69:5194–5201. CrossRef
- Yu J, Tao Q, Cheung KF, et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase l1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology. 2008;48:508–518. CrossRef
- Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage i lung cancer. N Engl J Med. 2008;358:1118–1128. CrossRef
- Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11:3286–3305. CrossRef
- Zhang WM, Lo Muzio L, Rubini C, Yan G. Effect of wnt-1 on beta-catenin expression and its relation to ki-67 and tumor differentiation in oral squamous cell carcinoma. Oncol Rep. 2005;13:1095–1099.
- Clement G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J. Alterations of the wnt signaling pathway during the neoplastic progression of Barrett’s esophagus. Oncogene. 2006;25:3084–3092. CrossRef
- Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of sfrp genes allows constitutive wnt signaling in colorectal cancer. Nat Genet. 2004;36:417–422. CrossRef
- Nojima M, Suzuki H, Toyota M, et al. Frequent epigenetic inactivation of sfrp genes and constitutive activation of wnt signaling in gastric cancer. Oncogene. 2007;26:4699–4713. CrossRef
- Finch PW, He X, Kelley MJ, et al. Purification and molecular cloning of a secreted, frizzled-related antagonist of wnt action. Proc Natl Acad Sci USA. 1997;94:6770–6775. CrossRef
- Chung MT, Sytwu HK, Yan MD, et al. Promoter methylation of sfrps gene family in cervical cancer. Gynecol Oncol. 2009;112:301–306. CrossRef
- Marsit CJ, McClean MD, Furniss CS, Kelsey KT. Epigenetic inactivation of the sfrp genes is associated with drinking, smoking and hpv in head and neck squamous cell carcinoma. Int J Cancer. 2006;119:1761–1766. CrossRef
- Caldwell GM, Jones C, Gensberg K, et al. The wnt antagonist sfrp1 in colorectal tumorigenesis. Cancer Res. 2004;64:883–888. CrossRef
- Smith E, De Young NJ, Pavey SJ, et al. Similarity of aberrant DNA methylation in Barrett’s esophagus and esophageal adenocarcinoma. Mol Cancer. 2008;7:75. CrossRef
- Veeck J, Niederacher D, An H, et al. Aberrant methylation of the wnt antagonist sfrp1 in breast cancer is associated with unfavourable prognosis. Oncogene. 2006;25:3479–3488. CrossRef
- He Y, Wang Y, Li P, et al. Identification of gpx3 epigenetically silenced by cpg methylation in human esophageal squamous cell carcinoma. Dig Dis Sci. 2011;56:681–688. CrossRef
- Milde-Langosch K, Bamberger AM, Rieck G, Kelp B, Loning T. Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Treat. 2001;67:61–70. CrossRef
- Sundararaj KP, Wood RE, Ponnusamy S, et al. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 2004;279:6152–6162. CrossRef
- He J, Sheng T, Stelter AA, et al. Suppressing wnt signaling by the hedgehog pathway through sfrp-1. J Biol Chem. 2006;281:35598–35602. CrossRef
- Berger SL. The complex language of chromatin regulation during transcription. Nature. 2007;447:407–412. CrossRef
- Armes JE, Hammet F, de Silva M, et al. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene. 2004;23:5697–5702. CrossRef
- Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O. Methylation-associated silencing of sfrp1 in renal cell carcinoma. Oncol Rep. 2008;20:1257–1263.
- Ali I, Rafiee P, Zheng Y, et al. Intramucosal distribution of wnt signaling components in human esophagus. J Clin Gastroenterol. 2009;43:327–337. CrossRef
- Baylin SB. Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin Cancer Biol. 2002;12:331–337. CrossRef
- Huang J, Zhang YL, Teng XM, et al. Down-regulation of sfrp1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer. 2007;7:126. CrossRef
- Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 2005;65:4218–4227. CrossRef
- Steele N, Finn P, Brown R, Plumb JA. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. Br J Cancer. 2009;100:758–763. CrossRef
- Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999;21:103–107. CrossRef
- Karpf AR, Jones DA. Reactivating the expression of methylation silenced genes in human cancer. Oncogene. 2002;21:5496–5503. CrossRef
- Belinsky SA, Klinge DM, Stidley CA, et al. Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res. 2003;63:7089–7093.
- Zhang C, Li H, Zhou G, et al. Transcriptional silencing of the tms1/asc tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol. 2007;212:134–142. CrossRef
- Plumb JA, Steele N, Finn PW, Brown R. Epigenetic approaches to cancer therapy. Biochem Soc Trans. 2004;32:1095–1097. CrossRef
- Chiurazzi P, Pomponi MG, Pietrobono R, et al. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the fmr1 gene. Hum Mol Genet. 1999;8:2317–2323. CrossRef
- Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T. DNA methyltransferase dnmt1 associates with histone deacetylase activity. Nat Genet. 2000;24:88–91. CrossRef
- Robertson KD, Ait-Si-Ali S, Yokochi T, et al. Dnmt1 forms a complex with rb, e2f1 and hdac1 and represses transcription from e2f-responsive promoters. Nat Genet. 2000;25:338–342. CrossRef
- Cervoni N, Szyf M. Demethylase activity is directed by histone acetylation. J Biol Chem. 2001;276:40778–40787. CrossRef
- Egger G, Aparicio AM, Escobar SG, Jones PA. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment. Cancer Res. 2007;67:346–353. CrossRef
- Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 2001;20:2536–2544. CrossRef
- Kapoor-Vazirani P, Kagey JD, Powell DR, Vertino PM. Role of hmof-dependent histone h4 lysine 16 acetylation in the maintenance of tms1/asc gene activity. Cancer Res. 2008;68:6810–6821. CrossRef
- Hu J, Dong A, Fernandez-Ruiz V, et al. Blockade of wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res. 2009;69:6951–6959. CrossRef
- Epigenetic Inactivation of the SFRP1 Gene in Esophageal Squamous Cell Carcinoma
Digestive Diseases and Sciences
Volume 56, Issue 11 , pp 3195-3203
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Esophageal squamous cell carcinoma
- DNA methylation
- Industry Sectors